Unknown
UT, US
Total Filings
6
Total Spending
$180K
About
Biopharmaceutical company focused on neurodegenerative diseases,including ALS
Recent Filings
2025 fourth_quarterQ4
CAPITOL HILL CONSULTING GROUP
$20K
1 month ago
2025 third_quarterQ3
CAPITOL HILL CONSULTING GROUP
$20K
4 months ago
2025 second_quarter2A
CAPITOL HILL CONSULTING GROUP
$20K
4 months ago
2025 first_quarter1A
CAPITOL HILL CONSULTING GROUP
$20K
4 months ago
2025 second_quarterQ2
CAPITOL HILL CONSULTING GROUP
$50K
7 months ago
2025 first_quarterQ1
CAPITOL HILL CONSULTING GROUP
$50K
10 months ago